Skip to main content
. 2008 Sep 10;82(22):11167–11180. doi: 10.1128/JVI.01218-08

TABLE 1.

Oligonucleotides used in this study

Name or locus Orientationa Sequence (5′→3′) Temp (°C)b Time (s)c PCR product (bp) Efficiencyd
MIE-P Fw CTTACGGGACTTTCCTACTTG 58 15 284 1.87
Rv CGATCTGACGGTTCACTAA
MIE-T Fw CCTAGTGTGGATGACCTA 58 8 112 1.88
Rv GTGACACCAGAGAATCAG
UL54-P Fw CACCAAAGACACGTCGTT 58 8 71 1.94
Rv GTCCTTTGCGACCAGAAT
UL54-T Fw GTGTGCAACTACGAGGTA 58 8 113 1.96
Rv GACAGCACGTTGGTTACA
UL32-P Fw ACTGGTACTGCGGTTCTA 58 8 150 1.88
Rv TCCACAACACCACGGTGA
UL32-T Fw CCGATTACAACGACGTCA 66-56e 8 106 1.77
Rv GTGGATGTCGTCGTCATT
oriLyt Fw GAATACAGCGATCCCTAG 58 10 171 1.86
Rv GGGTTCCACCTATCTGAA
GAPDH Fw CCTCACAGTTGCCATGTA 66-56e 8 71 1.97
Rv GATGGTACATGACAAGGTG
a

Fw, forward primer; Rv, reverse primer.

b

Annealing temperature used for PCR.

c

Polymerization time used for PCR.

d

PCR amplification efficiency determined as described in Roche Applied Science Technical Note no. LC 13/2001.

e

“Touch-down” conditions were used.